Biocon获得EMA批准在班加罗尔生产生物类似抗癌药物。

Biocon获得EMA批准在班加罗尔生产生物类似抗癌药物。

Biocon gets EMA’s nod to make biosimilar cancer drug at Bengaluru

作者: Aneeka Chatterjee

Bevacizumab is used to treat colon and rectal cancer, cervical cancer etc

贝伐珠单抗用于治疗结肠癌、直肠癌、宫颈癌等。

Bevacizumab is used to treat colon and rectal cancer, cervical cancer etc
Approval by the EMA will significantly enhance the capability to meet patient needs across European markets. The facility wa… [+1926 chars]

贝伐珠单抗用于治疗结肠癌、直肠癌、宫颈癌等。
欧洲药品管理局的批准将显著提高我们满足欧洲市场患者需求的能力。该设施的… [+1926个字符]

原文链接:Business Standard